Nektar Therapeutics (NKTR): Price and Financial Metrics
NKTR Price/Volume Stats
| Current price | $8.59 | 52-week high | $22.79 |
| Prev. close | $8.76 | 52-week low | $6.45 |
| Day low | $8.22 | Volume | 441,300 |
| Day high | $9.13 | Avg. volume | 171,221 |
| 50-day MA | $9.94 | Dividend yield | N/A |
| 200-day MA | $14.36 | Market Cap | 106.63M |
NKTR Stock Price Chart Interactive Chart >
Nektar Therapeutics (NKTR) Company Bio
Nektar Therapeutics is a biopharmaceutical company, developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives, and immunology.
NKTR Price Returns
| 1-mo | -16.40% |
| 3-mo | -37.02% |
| 6-mo | -43.86% |
| 1-year | -51.05% |
| 3-year | -82.33% |
| 5-year | -97.31% |
| YTD | -38.42% |
| 2024 | 64.60% |
| 2023 | -75.00% |
| 2022 | -83.27% |
| 2021 | -20.53% |
| 2020 | -21.24% |
Continue Researching NKTR
Want to do more research on Nektar Therapeutics's stock and its price? Try the links below:Nektar Therapeutics (NKTR) Stock Price | Nasdaq
Nektar Therapeutics (NKTR) Stock Quote, History and News - Yahoo Finance
Nektar Therapeutics (NKTR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...